Rate of cognitive decline (RCD) in Alzheimer’s disease (AD) determines the degree of impairment for patients and of burden for caretakers. We studied the association of RCD with genetic variants in AD.
RCD was evaluated in 62 familial AD (FAD) and 53 sporadic AD (SAD) cases, and analyzed by whole-exome sequencing for association with common exonic functional variants. Findings were validated in post mortem brain tissue.
One hundred seventy-two gene variants in FAD, and 227 gene variants in SAD associated with RCD. In FAD, performance decline of the immediate recall of the Rey-Osterrieth figure test associated with 122 genetic variants. Olfactory receptor OR51B6 showed the highest number of associated variants. Its expression was detected in temporal cortex neurons.
Impaired olfactory function has been associated with cognitive impairment in AD. Genetic variants in these or other genes could help to identify risk of faster memory decline in FAD and SAD patients.

If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.

This post is Copyright: Diego Sepulveda‐Falla,
Jorge I. Vélez,
Natalia Acosta‐Baena,
Ana Baena,
Sonia Moreno,
Susanne Krasemann,
Francisco Lopera,
Claudio A. Mastronardi,
Mauricio Arcos‐Burgos | March 7, 2024

Wiley: Alzheimer’s & Dementia: Table of Contents